Skip to main content
Originalarbeit

Exekutive Dysfunktion bei Neurofibromatose Typ 1: Welche Rolle spielt ADHS?

Published Online:https://doi.org/10.1024/1016-264X/a000217

Zusammenfassung. Neurofibromatose Typ 1 (NF1) ist eine seltene genetische Erkrankung, die neben physischen Beeinträchtigungen maßgeblich neuropsychologische Probleme mit sich bringt. Besonders alltagsrelevant sind hierbei exekutive Dysfunktionen. Bei 30 bis 50 % aller Kinder mit NF1 kann außerdem eine komorbide Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) diagnostiziert werden. Da exekutive Dysfunktionen als eines der Kernsymptome der ADHS gelten, wurde in der vorliegenden Studie untersucht, ob NF1-Patienten generell von exekutiven Dysfunktionen betroffen sind oder nur eine Subgruppe mit komorbider ADHS. Zudem wurde geprüft, ob sich Patienten mit reiner ADHS und Patienten mit ADHS bei NF1 in ihren exekutiven Dysfunktionen ähneln. Es zeigte sich, dass NF1-Patienten ohne ADHS in ihren exekutiven Funktionen nicht beeinträchtigt sind, eine komorbide ADHS jedoch mit exekutiven Auffälligkeiten assoziiert ist.


The Impact of ADHD on Executive Dysfunctions in Neurofibromatosis Type 1

Abstract. In addition to having physical complications, children with neurofibromatosis type 1 (NF1) show a wide spectrum of neuropsychological deficits, mainly executive dysfunctions. Approximately 30 % to 50 % of NF1-patients are also diagnosed with a comorbid attention-deficit/hyperactivity disorder (ADHD). Since executive dysfunctions are a core component in ADHD, this study was conceived to show whether executive dysfunctions are genuinely a problem in NF1 – or just one of an ADHD subgroup. Additionally, we investigated whether executive dysfunctions in NF1 differ from those observed in pure ADHD. According to our findings, NF1-patients without ADHD do not show any executive dysfunctions; however, NF1-patients with ADHD exhibit serious impairments. These results show that executive dysfunctions are not a core deficit of NF1 but rather one of ADHD.

Literatur

  • Aschenbrenner, S., Tucha, O. & Lange, K. W. (2000). Regensburger Wortflüssigkeits-Test (RWT). Göttingen: Hogrefe. First citation in articleGoogle Scholar

  • Biederman, J., Monuteaux, M. C., Doyle, A. E., Seidman, L. J., Wilens, T. E. & Ferrero, F. et al. (2004). Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. Journal of Consulting and Clinical Psychology, 72(5), 757. First citation in articleGoogle Scholar

  • Bodnar, L. E., Prahme, M. C., Cutting, L. E., Denckla, M. B. & Mahone, E. M. (2007). Construct validity of parent ratings of inhibitory control. Child Neuropsychology, 13(4), 345–362. First citation in articleCrossrefGoogle Scholar

  • Casnar, C. L. & Klein-Tasman, B. P. (2016). Parent and Teacher Perspectives on Emerging Executive Functioning in Preschoolers With Neurofibromatosis Type 1: Comparison to Unaffected Children and Lab-Based Measures. Journal of Pediatric Psychology, 42(2), 198–207. First citation in articleGoogle Scholar

  • Chan, R. C., Shum, D., Toulopoulou, T. & Chen, E. Y. (2008). Assessment of executive functions: Review of instruments and identification of critical issues. Archives of Clinical Neuropsychology, 23(2), 201–216. First citation in articleCrossrefGoogle Scholar

  • Cutting, L. E., Huang, G., Zeger, S., Koth, C. W., Thompson, R. E. & Denckla, M. B. (2002). Growth curve analyses of neuropsychological profiles in children with neurofibromatosis type 1: Specific cognitive tests remain „spared“ and „impaired“ over time. Journal of the International Neuropsychological Society, 8(6), 838–846. First citation in articleCrossrefGoogle Scholar

  • Descheemaeker, M. J., Ghesquière, P., Symons, H., Fryns, J.-P. & Legius, E. (2005). Behavioural, academic and neuropsychological profile of normally gifted neurofibromatosis type 1 children. Journal of Intellectual Disability Research, 49(1), 33–46. First citation in articleCrossrefGoogle Scholar

  • Diamantopoulou, S., Rydell, A.-M., Thorell, L. B. & Bohlin, G. (2007). Impact of executive functioning and symptoms of attention deficit hyperactivity disorder on children’s peer relations and school performance. Developmental Neuropsychology, 32(1), 521–542. First citation in articleCrossrefGoogle Scholar

  • Diggs-Andrews, K. A. & Gutmann, D. h. (2013). Modeling cognitive dysfunction in neurofibromatosis-1. Trends in Neurosciences, 36(4), 237–247. First citation in articleCrossrefGoogle Scholar

  • Doyle, A. E. (2006). Executive functions in attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 67(suppl 8), 21–26. First citation in articleGoogle Scholar

  • Friedman, J. M. (1999). Epidemiology of neurofibromatosis type 1. American Journal of Medical Genetics, 89(1), 1–6. First citation in articleCrossrefGoogle Scholar

  • Gilboa, Y., Rosenblum, S., Fattal-Valevski, A., Toledano-Alhadef, H. & Josman, N. (2014). Is there a relationship between execu- tive functions and academic success in children with neurofibromatosis type 1? Neuropsychological Rehabilitation, 24(6), 918–935. First citation in articleCrossrefGoogle Scholar

  • Gioia, G. A. (2000). BRIEF: Behavior Rating Inventory of Executive Function: Professional manual. Lutz, FL: Psychological Assessment Resources. First citation in articleGoogle Scholar

  • Grafman, J. & Litvan, I. (1999). Importance of deficits in executive functions. Lancet, 354(9194), 1921–1923. First citation in articleCrossrefGoogle Scholar

  • Haber, S. N. (2003). The primate basal ganglia: parallel allel and integrative networks. Journal of Chemical Neuroanatomy, 26(4), 317–330. First citation in articleCrossrefGoogle Scholar

  • Hyman, S. L., Gill, D., Shores, E., Steinberg, A., Joy, P. & Gibikote, S. et al. (2003). Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology, 60(7), 1139–1145. First citation in articleCrossrefGoogle Scholar

  • Hyman, S. L., Shores, E. A. & North, K. N. (2006). Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine & Child Neurology, 48(12), 973–977. First citation in articleCrossrefGoogle Scholar

  • Kehrer-Sawatzki, H. & Mautner, V.-F. (2009). Klinik und Genetik der Neurofibromatose Typ 1. Medizinische Genetik, 21(4), 519–531. First citation in articleCrossrefGoogle Scholar

  • Levy, K. J. (1980). A Monte Carlo study of analysis of covariance under violations of the assumptions of normality and equal regression slopes. Educational and Psychological Measurement, 40(4), 835–840. First citation in articleCrossrefGoogle Scholar

  • Lidzba, K., Christiansen, H. & Drechsler, R. (2013). Conners 3®: Conners Skalen zu Aufmerksamkeit und Verhalten – 3. Manual. Bern: Huber. First citation in articleGoogle Scholar

  • Lidzba, K., Granström, S., Lindenau, J. & Mautner, V. (2012). The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1. Developmental Medicine & Child Neurology, 54(10), 892–897. First citation in articleCrossrefGoogle Scholar

  • Mahone, E. M., Hagelthorn, K. M., Cutting, L. E., Schuerholz, L. J., Pelletier, S. F. & Rawlins, C. et al. (2002). Effects of IQ on executive function measures in children with ADHD. Child Neuropsychology, 8(1), 52–65. First citation in articleCrossrefGoogle Scholar

  • Mautner, V.-F., Kluwe, L., Thakker, S. D. & Leark, R. A. (2002). Treatment of ADHD in neurofibromatosis type 1. Developmental Medicine & Child Neurology, 44(03), 164–170. First citation in articleCrossrefGoogle Scholar

  • North, K. (2000). Neurofibromatosis type 1. American Journal of Medical Genetics, 97(2), 119–127. First citation in articleCrossrefGoogle Scholar

  • North, K., Hyman, S. & Barton, B. (2002). Review article: cognitive deficits in neurofibromatosis 1. Journal of Child Neurology, 17(8), 605–612. First citation in articleCrossrefGoogle Scholar

  • Oliveira, A. F. & Yasuda, R. (2014). Neurofibromin is the major ras inactivator in dendritic spines. Journal of Neuroscience, 34(3), 776–783. First citation in articleCrossrefGoogle Scholar

  • Ozonoff, S. (1999). Cognitive impairment in neurofibromatosis type 1. American Journal of Medical Genetics, 89(1), 45–52. First citation in articleCrossrefGoogle Scholar

  • Payne, J. M., Arnold, S. S., Pride, N. A. & North, K. N. (2012). Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1? Developmental Medicine & Child Neurology, 54(10), 898–904. First citation in articleCrossrefGoogle Scholar

  • Payne, J. M., Hyman, S. L., Shores, E. A. & North, K. N. (2011). Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychology, 17(4), 313–329. First citation in articleCrossrefGoogle Scholar

  • Petermann, F. & Petermann, U. (2007). Hamburg-Wechsler-Intelligenztest für Kinder-IV (HAWIK-IV). Bern: Huber. First citation in articleGoogle Scholar

  • Potvin, D., Hardy, K. K. & Walsh, K. S. (2015). The Relation Between ADHD and Cognitive Profiles of Children with NF1. Journal of Pediatric Neuropsychology, 1(1–4), 42–49. First citation in articleCrossrefGoogle Scholar

  • Pride, N. A., Payne, J. M. & North, K. N. (2012). The impact of ADHD on the cognitive and academic functioning of children with NF1. Developmental Neuropsychology, 37(7), 590–600. First citation in articleCrossrefGoogle Scholar

  • Raaijmakers, M. A., Smidts, D. P., Sergeant, J. A., Maassen, G. H., Posthumus, J. A. & Van Engeland, H. et al. (2008). Executive functions in preschool children with aggressive behavior: Impairments in inhibitory control. Journal of Abnormal Child Psychology, 36(7), 1097–1107. First citation in articleCrossrefGoogle Scholar

  • Reitan, R. (1992). Trail Making Test. Manual for administration and scoring. South Tucson, AR: Reitan Neuropsychology Laboratory. First citation in articleGoogle Scholar

  • Rosenbaum, T. (2003). Neurokutane Syndrome. In M. J. Lentze, F. J. Schulte, J. Schaub & J. Spranger (Hrsg.), Pädiatrie. Grundlagen und Praxis (2. Aufl., S. 1373–1379). Berlin: Springer. First citation in articleGoogle Scholar

  • Roy, A., Barbarot, S., Roulin, J.-L., Charbonnier, V., Fasotti, L. & Stalder, J.-F., et al. (2014). Is executive function specifically impaired in children with Neurofibromatosis type 1? A neuropsychological investigation of cognitive flexibility. Applied Neuropsychology: Child, 3(2), 94–102. First citation in articleCrossrefGoogle Scholar

  • Sarsour, K., Sheridan, M., Jutte, D., Nuru-Jeter, A., Hinshaw, S. & Boyce, W. T. (2011). Family socioeconomic status and child executive functions: the roles of language, home environment, and single parenthood. Journal of the International Neuropsychological Society, 17(01), 120–132. First citation in articleCrossrefGoogle Scholar

  • Seidman, L. J. (2006). Neuropsychological functioning in people with ADHD across the lifespan. Clinical Psychology Review, 26(4), 466–485. First citation in articleCrossrefGoogle Scholar

  • Stumpf, D. A., Alksne, J. F. & Annegers, J. F. (1988). Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Archives of Neurology, 45, 575–578. First citation in articleGoogle Scholar

  • Weiss, B., Bollag, G. & Shannon, K. (1999). Hyperactive Ras as a therapeutic target in neurofibromatosis type 1. American Journal of Medical Genetics, 89(1), 14–22. First citation in articleCrossrefGoogle Scholar

  • Winkler, J. & Stolzenberg, H. (2009). Adjustment of the social class index for application in the german health interview and examination survey for children and adolescents (KiGGS). Wismar: HWS-Hochschule Wismar. First citation in articleGoogle Scholar